跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Kabiroc - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Kabiroc
Approved
STANDARD
Kabiroc
Fresenius Kabi Austria GmbH
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
fc58b4e9301bdcf8
Company
Fresenius Kabi Austria GmbH
Type
Standard
Approval Details
Approval Id
fc58b4e9301bdcf8
Drug Approval Philippines Name
Kabiroc
Product Name
Kabiroc
Registration Number
DR-XY49319
Brand Name
Kabiroc
Generic Name
Rocuronium Bromide
Dosage Form
Solution for Injection (IV)
Dosage Strength
10 mg/mL
Manufacturer
Fresenius Kabi Austria GmbH
Importer
Fresenius Kabi Philippines, Inc.
Distributor
Fresenius Kabi Philippines, Inc.
Company Detail Path
/organization/fresenius-kabi-austria-gmbh
Issuance Date
28 January 2025
Expiry Date
28 January 2030
Pharmacologic Category
Muscle Relaxant
Classification
Prescription (Rx) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
fc58b4e9301bdcf8
Type
Standard
Back to Philippines FDA Approvals